Cargando…
Safety and efficacy of off-label use of ivabradine in patients with acute heart failure
BACKGROUND: Ivabradine is approved to improve exercise tolerance and quality of life in patients with chronic heart failure; its use in acute heart failure (AHF) has not previously been studied. METHODS: Forty adult patients admitted with AHF were randomized into two groups; Group 1 patients were pr...
Autores principales: | Othman, Khaled M. Said, Mostafa, Mohamed Ahmed Radwan, Yosef, Ahmed Elsayed, Abdeltawab, Adham Ahmed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614597/ https://www.ncbi.nlm.nih.gov/pubmed/31333320 http://dx.doi.org/10.1016/j.jsha.2019.05.006 |
Ejemplares similares
-
Ivabradine tolerability in heart failure
por: Birkhoelzer, Sarah, et al.
Publicado: (2018) -
Safety and efficacy of omecamtiv mecarbil for heart failure: A systematic review and meta-analysis
por: Alqatati, Fadel, et al.
Publicado: (2022) -
Advances in the management of heart failure: the role of ivabradine
por: Müller-Werdan, Ursula, et al.
Publicado: (2016) -
Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial
por: Bocchi, Edimar Alcides, et al.
Publicado: (2017) -
A Phase 4, Open-Label, Single-Arm Study Assessing the Efficacy and Safety of Ivabradine in African American Patients with Heart Failure and Reduced Ejection Fraction
por: Lanfear, David E., et al.
Publicado: (2020)